Results 31 to 40 of about 800,324 (296)

Variations in the body mass index in Brazilian women undergoing adjuvant chemotherapy for breast cancer [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia, 2014
PURPOSE:To evaluate variations in the body mass index in patients undergoing adjuvant chemotherapy for breast cancer, and to associate these changes with patient's age and adjuvant chemotherapy regimen.METHODS:We performed a retrospective cohort study in
Marcos Desídérío Ricci   +7 more
doaj   +2 more sources

Adjuvant chemotherapy in the elderly

open access: yesAnnals of Oncology, 2003
Cancer is predominantly a disease of the elderly: approximately 60% of all tumors and two-thirds of cancer-related deaths occur in those over 65 years of age. This proportion will grow with the expected increase in the size of the older population in the coming decades.
Biganzoli, Laura, Aapro, Matti
openaire   +3 more sources

Factors related to patient propensity to receive adjuvant chemotherapy and outcomes in stage III gastric cancer cases after D2 surgery

open access: yesAsian Journal of Surgery, 2019
Summary: Background: Radical gastrectomy and extended lymph node (D2) dissection followed by adjuvant chemotherapy is the optimal treatment for patients with stage III gastric cancer in Asian population.
Jen-Shi Chen   +6 more
doaj   +1 more source

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy [PDF]

open access: yes, 2016
How chemotherapy affects carcinoma genomes is largely unknown. Here we report whole-exome and deep sequencing of 30 paired oesophageal adenocarcinomas sampled before and after neo-adjuvant chemotherapy.
MacGregor, T.P.   +11 more
core   +1 more source

Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial

open access: yesBMC Cancer, 2018
Background Some patients develop recurrence after curative resection and adjuvant chemotherapy. S-1, an oral fluoropyrimidine, is one of the standard regimens in adjuvant chemotherapy, and is also used in first-line treatment for advanced/metastatic ...
Seiji Ito, Yasuo Ohashi, Mitsuru Sasako
doaj   +1 more source

Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma

open access: yesFrontiers in Oncology, 2022
BackgroundAdjuvant chemotherapy has been shown to produce a favorable prognosis for patients with resectable mucosal melanoma (MM), resulting in the need for stratification to optimally select patients to benefit from adjuvant therapy.
Lirui Tang   +21 more
doaj   +1 more source

Node-positive breast cancer: Which are the best chemotherapy regimens? [PDF]

open access: yes, 2008
Breast cancer-associated mortality has been significantly reduced since the 1990s, mainly because of early diagnosis and systemic therapeutic interventions.
Bauerfeind, Ingo   +6 more
core   +1 more source

Hormones and adjuvant chemotherapy in breast-cancer

open access: yes, 1977
This article discusses hormones and adjuvant chemotherapy in breast ...
Algie, T.   +3 more
core   +4 more sources

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery [PDF]

open access: yes, 2010
BACKGROUND: In newly diagnosed patients with Hodgkin lymphoma (HL) the effect of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD)-related neutropenia on chemotherapy delivery is poorly documented.
Lyman, Gary H.   +28 more
core   +1 more source

The practical roadmap for peri-cystectomy approaches in muscle-invasive bladder cancer

open access: yesFrontiers in Oncology
The management of muscle-invasive bladder cancer (MIBC) remains a challenging topic since it is witnessing rapidly evolving changes and new drug approvals. In fact, more effective approaches are now available to improve the outcomes of patients with MIBC
Joseph Kattan   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy